SynthesisFrontiers in medicine2026
The predictive value of abnormal uteroplacental and fetal Doppler indices for adverse perinatal outcomes in hypertensive disorders of pregnancy: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically evaluate the predictive value of abnormal uteroplacental and fetal Doppler indices for adverse perinatal outcomes in patients with hypertensive disorders of pregnancy (HDP), quantify the strength of association, and assess the certainty of evidence to optimize prenatal monitoring protocols. Methods: Based on PRISMA guidelines, we searched Cochrane CENTRAL, PubMed, Embase, and SCIE for observational cohort studies published between January 2016 and March 2026. Included studies comprised singleton pregnant women with HDP who underwent uteroplacental and fetal Doppler assessment (e.g., UtA-PI, UA, MCA, or CPR) and reported perinatal outcomes. Risk of bias was assessed using the Newcastle-Ottawa Scale (NOS), and the certainty of evidence was graded using the GRADE framework. This study was registered with PROSPERO (CRD420261331863). Results: Thirteen cohort studies involving 1,744 patients (25 independent datasets) were included. Meta-analysis revealed that HDP patients with abnormal uteroplacental and fetal Doppler indices had a significantly elevated risk of adverse perinatal outcomes (RR = 2.26, 95% CI: 1.93-2.64, Conclusion: Abnormal uteroplacental and fetal Doppler indices, particularly UtA-PI and CPR, are strongly associated with adverse perinatal outcomes in HDP patients. UtA-PI serves as a stable mid-trimester risk-stratification tool, while CPR functions as a valuable supplementary index in the third trimester. We recommend a multi-parametric, sequential monitoring workflow for HDP management. Future research should prioritize establishing standardized, gestational-age-specific diagnostic thresholds for CPR to enhance clinical precision. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261331863, identifier CRD420261331863.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.